China BCT Pharmacy Group, Inc.
CNBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.29 | 0.37 | -0.00 |
| FCF Yield | -201.16% | -13.65% | 16.56% | 8.23% |
| EV / EBITDA | 0.07 | 1.02 | 2.28 | 2.95 |
| Quality | ||||
| ROIC | 11.56% | 19.52% | 27.34% | 30.54% |
| Gross Margin | 20.13% | 24.01% | 24.31% | 26.09% |
| Cash Conversion Ratio | -0.46 | -0.16 | 0.62 | 0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.40% | 23.68% | – | – |
| Free Cash Flow Growth | -66.52% | -159.71% | 125.41% | 34,949.98% |
| Safety | ||||
| Net Debt / EBITDA | -0.17 | -0.49 | -0.25 | -0.01 |
| Interest Coverage | 25.47 | 47.30 | 40.27 | 19.06 |
| Efficiency | ||||
| Inventory Turnover | 14.20 | 13.80 | 14.10 | 11.50 |
| Cash Conversion Cycle | 183.46 | 123.98 | 73.25 | 75.43 |